Member Info for Metaltiger

Hi Chester,
Many thanks for your comprehensive post I really appreciate the time and trouble you went to.
It’s also good to see a positive BB here I will keep my eye on the ball here as like I previously said I like very much what I see.
Also I’d like to say thank you to Thornton for the response also.
That aside I wish everyone here a great weekend.
Regards,
Tiger:)

Hi,
I’m relatively new to trx and have been watching on the sidelines so to speak.
I am very enthusiastic about current products etc and see good things down the road in time obviously covid is a burden regards operations etc.
I have looked into trx quite a lot but on the website on investors page who’s Richard griffiths and entities?
I’m however quite pleased that about 53% off shares are not in public hands.
Hopefully someone more clued up on trx can enlighten me, that aside I wish all involved the very best.
Regards,
Tiger :)

Cathal made it clear that pharma companies have in past focused on oncology programs. He then said there is a decade off vaccine testing etc.
So that should put to bed any short, medium or long term worries.
Also some off the jobs posted on hVIVO site are requesting you must be required to work at multiple sites.
I’m sure Cathal is looking way beyond covid and current facilities that we have etc!

Exactly ivy he’s always wanted cash sale the Nasdaq listing to me won’t happen.
Cash is king as they say!

Mine to is a £1 strictly I’m comfortable with that anything else a bonus.
Seems quite a few are at this number or thereabouts shareseeker and barwickman.
All well researched posters to!
I’m just happy to be in it and even more so for this reach it’s full potential.

Hi Mark,
I’m also glad you are in the black or near to it. Been done over myself in past and also sold out to early on another share and could off made a small fortune.
However that’s in the past and I’ve moved on , i wish all holders here the very best.
You will do well here with what’s looming just patience.
Anyway I wish everyone here a great weekend!

Pardon the pun but can we put this hospital issue to bed!
For the record he said central London.

The latest contract deal by the sounds off it is with AstraZeneca.
So In last couple off months bagged 3 top ten pharmaceutical companies.
Once the human challenge study gets full approval contracts be coming in here from all angles.
Regardless off size off companies the price set at a minimum off £7m.
Cathals done a fantastic job to get us to this stage in the timeframe it’s been achieved.
Good luck to all here!

I’m sure we all would off took this rise from Monday till now and we haven’t finished the week yet.
So who knows what’s going on in the background plenty I’d say off news and potential deals in the pipeline.
I personally think the latest recruitment off Robin Rogiers as off late is a nod in the direction off hcs getting approval.
I said this a week or two back don’t get me wrong great news that government are in talks etc.
I thought at the time that who would leave such a position at sgs and join a relatively new company etc.
She had worked at sgs Antwerp for 3 years plus so to upsticks leave your job, family, and friends etc a big move.
Just for the record her position at sgs reads as follows.
Principal investigator at sgs clinical pharmacology unit.
She specializes in early pharma clinical trials and focuses on the conduct off infectious diseases trials.
Such as vaccine trials and controlled human infection models.
I might be wrong but I’m thinking she was given a heads up on chances off success off hcs via Adrian Wildfire.
Again a cv anybody be proud off infectious disease specialist for over 30 years.
Also specialize in human challenge models for nearly 10
years. Also again while he was at sgs he was leading a multidisciplinary team manufacturing challenge agents for use in clinical trials.
So 3 weeks today option to acquire CHIMAgents.
One week today hVIVO at viral world vaccine congress Washington.
Also last week or two a additional 3 dates added to previous listing off presentations etc.
So forget current share price ups and downs it’s a long road ahead off many contracts here.
Apologies for length off message.
Tiger:)

True enough demon but these guys wouldn’t give a toss about me or you.
That’s life I guess full off winners and losers at least we are here at this point in charge off our own destiny. Yeah

I also raise a glass to all here and good luck to everyone going forward.
:)

Correct deep it was 9.56%.

Agree indiscipline with your points also deepjoy makes valid ones to.
The challenge study contracts are the main revenue driver here obviously subject to approval etc.
I think the move Cathal made on acquiring Adrian Wildfire was a great one together with rest off team from CHIMagents.
It’s ring fenced what we already had and surely will only help us in the development off study.
The recent recruitment off Robyn rodgier also from sgs I’m taking as a positive lately.
I’m sure she wouldn’t quit sgs to join a relatively new company if she thought it was a non-starter.

I know that the antibody testing is being bundled together with antigen testing offering broader testing to employer groups.
In last presentation he said it’s going very well since it’s all started never had any figures.
I wouldn’t mind any indication off this less than 500 a day or 500-1000?
Just anything very well means nothing without facts and figures.

Hi badshah,
All I can say is let the next 3 months pass then you won’t be disappointed.
That’s not a long time to wait to get a decent return on your investment.
However I don’t know your circumstances so like others have said each to their own etc.
I have had my fingers burnt on Aim and heard false promises etc.
However I’m more than happy here and as far as I’m concerned you would have to go a long way to better this share.
All said and done I wish you well whichever path you choose!
Tiger:)

On the 1.10.20 hVIVO are represented by Andrew Catchpole.
The clinical outcome of the development of an 60-75 year old RSV challenge model for evaluation of vaccines.
The list off companies that are on the website that we already deal with is great to see also.
The likes off Pfizer, GSK, DARPA, Janssen and Merck to name a few.
Also on the 30.9.20 Flugen are featured regarding the universal flu vaccine development.
Exciting times ahead the next few weeks and I’m sure plenty going on in the background also.
Good luck all!

Cathal did say in recent presentation that a few institutional investors will take profits.
Like he said they bought in at 11p and it could test 12.5p, 13.5p or 14.5p.
Everything he’s said has panned out so no worries from me nothings changed here.
How many other companies are out there like this, that’s even without us getting not one but two divideds in six months maximum.
It’s a no brainer that’s apart from share price rise between now and then.
Just sit tight it’s the right share in a perfect sector!

Hi Islandgirl,
Cathal said a few podcasts back judge me on mini milestones.
The timelines he gave were end September then end December.

Once the human challenge study gets the get go the phone will be ringing non stop.
Our profile will be raised hugely here and bringing us to the fore on testing and lab services.
Going forward that will bring us a constant and regular income.
We have courted the majors and I’m sure plenty off others will follow them to the font.

There’s so much to look forward to here apart from imutex all said and done will reap great rewards.
The human challenge study model and the wearable data combined be worth more.
Also raising our profile in Europe then America at trade shows etc.
It’s slowly coming together just patience and all things will fit into place here.
This is a company that has many strings to its bow all generating revenue.
Apart from that we have two pending dividend species in one form or another.
I’m very happy I’m invested here and yes heavily towards it like others.
You don’t look a gift horse in the mouth!
MT :)